Literature DB >> 22732306

Cholesterol metabolite, 5-cholesten-3β-25-diol-3-sulfate, promotes hepatic proliferation in mice.

Xin Zhang1, Qianming Bai, Genta Kakiyama, Leyuan Xu, Jin Kyung Kim, William M Pandak, Shunlin Ren.   

Abstract

UNLABELLED: Oxysterols are well known as physiological ligands of liver X receptors (LXRs). Oxysterols, 25-hydroxycholesterol (25HC) and 27-hydroxycholesterol as endogenous ligands of LXRs, suppress cell proliferation via LXRs signaling pathway. Recent reports have shown that sulfated oxysterol, 5-cholesten-3β-25-diol-3-sulfate (25HC3S) as LXRs antagonist, plays an opposite direction to oxysterols in lipid biosynthesis. The present report was to explore the effect and mechanism of 25HC3S on hepatic proliferation in vivo. Following administration, 25HC3S had a 48 h half life in the circulation and widely distributed in mouse tissues. Profiler™ PCR array and RTqPCR analysis showed that either exogenous or endogenous 25HC3S generated by overexpression of oxysterol sulfotransferase (SULT2B1b) plus administration of 25HC significantly up-regulated the proliferation gene expression of Wt1, Pcna, cMyc, cyclin A, FoxM1b, and CDC25b in a dose-dependent manner in liver while substantially down-regulating the expression of cell cycle arrest gene Chek2 and apoptotic gene Apaf1. Either exogenous or endogenous administration of 25HC3S significantly induced hepatic DNA replication as measured by immunostaining of the PCNA labeling index and was associated with reduction in expression of LXR response genes, such as ABCA1 and SREBP-1c. Synthetic LXR agonist T0901317 effectively blocked 25HC3S-induced hepatic proliferation.
CONCLUSIONS: 25HC3S may be a potent regulator of hepatocyte proliferation and oxysterol sulfation may represent a novel regulatory pathway in liver proliferation via inactivating LXR signaling.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22732306      PMCID: PMC3463675          DOI: 10.1016/j.jsbmb.2012.06.001

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  58 in total

Review 1.  Liver X receptors as therapeutic targets in metabolism and atherosclerosis.

Authors:  Takashi Nomiyama; Dennis Bruemmer
Journal:  Curr Atheroscler Rep       Date:  2008-02       Impact factor: 5.113

2.  Oxysterol-induced cell death in U937 and HepG2 cells at reduced and normal serum concentrations.

Authors:  Y C O'Callaghan; J A Woods; N M O'Brien
Journal:  Eur J Nutr       Date:  1999-12       Impact factor: 5.614

Review 3.  Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene.

Authors:  Vicki Huff
Journal:  Nat Rev Cancer       Date:  2011-01-20       Impact factor: 60.716

4.  Sulfotransferase forms expressed in human intestinal Caco-2 and TC7 cells at varying stages of differentiation and role in benzo[a]pyrene metabolism.

Authors:  Walter Meinl; Bettina Ebert; Hansruedi Glatt; Alfonso Lampen
Journal:  Drug Metab Dispos       Date:  2007-10-29       Impact factor: 3.922

5.  Cholesterol, LDL, and 25-hydroxycholesterol regulate expression of the steroidogenic acute regulatory protein in microvascular endothelial cell line (bEnd.3).

Authors:  Yanxia Ning; Sifeng Chen; Xiaobo Li; Yongjie Ma; Fengdi Zhao; Lianhua Yin
Journal:  Biochem Biophys Res Commun       Date:  2006-02-28       Impact factor: 3.575

Review 6.  Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL.

Authors:  Michael S Brown; Joseph L Goldstein
Journal:  J Lipid Res       Date:  2008-10-29       Impact factor: 5.922

7.  24-hydroxycholesterol sulfation by human cytosolic sulfotransferases: formation of monosulfates and disulfates, molecular modeling, sulfatase sensitivity, and inhibition of liver x receptor activation.

Authors:  Ian T Cook; Zofia Duniec-Dmuchowski; Thomas A Kocarek; Melissa Runge-Morris; Charles N Falany
Journal:  Drug Metab Dispos       Date:  2009-07-09       Impact factor: 3.922

8.  The oxysterol receptor LXR inhibits proliferation of human breast cancer cells.

Authors:  Lise-Lotte Vedin; Sebastian A Lewandowski; Paolo Parini; Jan-Ake Gustafsson; Knut R Steffensen
Journal:  Carcinogenesis       Date:  2009-01-23       Impact factor: 4.944

9.  LXR signaling couples sterol metabolism to proliferation in the acquired immune response.

Authors:  Steven J Bensinger; Michelle N Bradley; Sean B Joseph; Noam Zelcer; Edith M Janssen; Mary Ann Hausner; Roger Shih; John S Parks; Peter A Edwards; Beth D Jamieson; Peter Tontonoz
Journal:  Cell       Date:  2008-07-11       Impact factor: 41.582

10.  25-hydroxycholesterol provokes oligodendrocyte cell line apoptosis and stimulates the secreted phospholipase A2 type IIA via LXR beta and PXR.

Authors:  Amalia Trousson; Sophie Bernard; Patrice X Petit; Philippe Liere; Antoine Pianos; Khadija El Hadri; Jean-Marc A Lobaccaro; M Said Ghandour; Michel Raymondjean; Michael Schumacher; Charbel Massaad
Journal:  J Neurochem       Date:  2009-02-24       Impact factor: 5.372

View more
  9 in total

1.  Synthesis and Application of Injectable Bioorthogonal Dendrimer Hydrogels for Local Drug Delivery.

Authors:  Leyuan Xu; Remy C Cooper; Juan Wang; W Andrew Yeudall; Hu Yang
Journal:  ACS Biomater Sci Eng       Date:  2017-06-21

Review 2.  Sulfation of 25-hydroxycholesterol regulates lipid metabolism, inflammatory responses, and cell proliferation.

Authors:  Shunlin Ren; Yanxia Ning
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-12-03       Impact factor: 4.310

3.  Oxysterol binding protein-related protein 8 mediates the cytotoxicity of 25-hydroxycholesterol.

Authors:  Jiwei Li; Xiuting Zheng; Ning Lou; Wenbin Zhong; Daoguang Yan
Journal:  J Lipid Res       Date:  2016-08-16       Impact factor: 5.922

Review 4.  Cholesterol Metabolites 25-Hydroxycholesterol and 25-Hydroxycholesterol 3-Sulfate Are Potent Paired Regulators: From Discovery to Clinical Usage.

Authors:  Yaping Wang; Xiaobo Li; Shunlin Ren
Journal:  Metabolites       Date:  2020-12-25

5.  25-Hydroxycholesterol 3-Sulfate Recovers Acetaminophen Induced Acute Liver Injury via Stabilizing Mitochondria in Mouse Models.

Authors:  Yaping Wang; William M Pandak; Edward J Lesnefsky; Phillip B Hylemon; Shunlin Ren
Journal:  Cells       Date:  2021-11-05       Impact factor: 6.600

6.  Disrupting LXRα phosphorylation promotes FoxM1 expression and modulates atherosclerosis by inducing macrophage proliferation.

Authors:  M C Gage; N Bécares; R Louie; K E Waddington; Y Zhang; T H Tittanegro; S Rodríguez-Lorenzo; A Jathanna; B Pourcet; O M Pello; J V De la Rosa; A Castrillo; I Pineda-Torra
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-27       Impact factor: 11.205

7.  Hydroxysteroid sulfotransferase SULT2B1b promotes hepatocellular carcinoma cells proliferation in vitro and in vivo.

Authors:  Xiaoming Yang; Yali Xu; Fenghua Guo; Yanxia Ning; Xiuling Zhi; Lianhua Yin; Xiaobo Li
Journal:  PLoS One       Date:  2013-04-11       Impact factor: 3.240

8.  Identification of novel regulatory cholesterol metabolite, 5-cholesten, 3β,25-diol, disulfate.

Authors:  Shunlin Ren; Jin Koung Kim; Genta Kakiyama; Daniel Rodriguez-Agudo; William M Pandak; Hae-Ki Min; Yanxia Ning
Journal:  PLoS One       Date:  2014-07-29       Impact factor: 3.240

9.  Liver X receptor α is essential for the capillarization of liver sinusoidal endothelial cells in liver injury.

Authors:  Yan Xing; Tingting Zhao; Xiaoyan Gao; Yuzhang Wu
Journal:  Sci Rep       Date:  2016-02-18       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.